The August 2019 edition of Toxicological Sciences—Volume 170, Issue 2—continues progressing “strategies . . . for the future benefit of the journal,” in accordance with the vision of Editor-in-Chief Jeffrey M. Peters, PhD.
Among the leading toxicological research published in the August issue are several Tox Spotlight articles. Introduced in July, Tox Spotlight is a new designation bestowed upon certain pieces in each edition of ToxSci. Four Tox Spotlight articles are featured in Volume 170, Issue 2:
- “A CRISPR/Cas9 Whole-Genome Screen Identifies Genes Required for Aryl Hydrocarbon Receptor-Dependent Induction of Functional CYP1A1”
- “Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites”
- “Differential Sensitivity to In Vitro Inhibition of Cytochrome P450 Aromatase (CYP19) Activity among 18 Freshwater Fishes”
- “The TGFβ1 Receptor Antagonist GW788388 Reduces JNK Activation and Protects against Acetaminophen Hepatotoxicity in Mice”
The August issue also includes two Contemporary Reviews:
- “Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities”
- “Predicting Human Infection Risk: Do Rodent Host Resistance Models Add Value?”
Further, articles covering carcinogenesis, developmental and reproductive toxicology, computational toxicology, and more are available in Volume 170, Issue 2, of the journal.
The mission of Toxicological Sciences is to publish a broad spectrum of impactful research in the field of toxicology.
